Treatment for asthma. (TY Atid-EDI) Israel’s Teva has bought the rights to complete the development of BD9 – an antibody-based therapy for the treatment of asthma and atopic dermatitis from Israel’s Biolojic Design (see here previously). Biolojic’s AI platform generates antibodies that have predictable functions.
Treatment for asthma
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.